Agilent Technologies Q3 FY2026 results
$173.96+0.55%
Agilent Technologies reported revenue of $1.88 billion, up 8.1% from a year earlier, net income of $362 million and diluted earnings per share of $1.28 against $1.18 for the third quarter of fiscal 2026 (the three months to 31 Jul 2026).
From its quarterly report, the results first announced on 26 Aug 2026. Compiled and checked by AapWire.
Q3 FY2026 against Q3 FY2025
Three months to 31 Jul 2026, against the three months to 31 Jul 2025. Amounts in USD.
| Measure | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | $1.88B | $1.74B | +8.1% |
| Gross profit | $1.04B | $888.0M | +17.3% |
| Gross margin | 55.5% | 51.1% | +4.4 pts |
| Operating income | $444.0M | $360.0M | +23.3% |
| Operating margin | 23.6% | 20.7% | +2.9 pts |
| Net income | $362.0M | $336.0M | +7.7% |
| Diluted EPS | $1.28 | $1.18 | +8.5% |
| Operating cash flow | $519.0M | $362.0M | +43.4% |
| Capital expenditure | $80.00M | $103.0M | −22.3% |
| Free cash flow | $439.0M | $259.0M | +69.5% |
Operating KPIs for the quarter
| KPI | Q3 FY2026 | Change on a year |
|---|---|---|
| Product revenue | $1.3B | up 8.4% |
| Non-Instrumentation and Other revenue | $1.2B | up 8.4% |
| Instrumentation revenue | $643.0M | up 7.3% |
| Services and Other revenue | $545.0M | up 7.3% |
| Agilent CrossLab revenue | $786.0M | up 5.6% |
| Life Sciences and Diagnostics Markets revenue | $746.0M | up 11.3% |
| Applied Markets revenue | $346.0M | up 6.8% |
| Americas revenue | $761.0M | up 11.4% |
| Asia Pacific revenue | $613.0M | up 8.9% |
| Europe revenue | $504.0M | up 2.4% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | 31 Jul 2026 | $1.88B | +8.1% | $1.28 |
| Q2 FY2026 | 30 Apr 2026 | $1.83B | +10.0% | $1.20 |
| Q1 FY2026 | 31 Jan 2026 | $1.80B | +7.0% | $1.07 |
| Q4 FY2025 | 31 Oct 2025 | $1.86B | +9.4% | $1.52 |
| Q3 FY2025 | 31 Jul 2025 | $1.74B | +10.1% | $1.18 |
| Q2 FY2025 | 30 Apr 2025 | $1.67B | +6.0% | $0.75 |
| Q1 FY2025 | 31 Jan 2025 | $1.68B | +1.4% | $1.11 |
| Q4 FY2024 | 31 Oct 2024 | $1.70B | +0.8% | $1.23 |
More on Agilent Technologies: financial statements · revenue · earnings per share
A's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.